Canaccord Genuity

Canaccord Genuity Group Inc. is a leading independent, full-service financial services firm specializing in wealth management and capital markets, with significant expertise advising healthcare and life sciences companies on M&A, capital raising, and strategic transactions. The firm itself does not conduct clinical research or have clinical results. It has been recognized as one of the top global financial advisors by deal volume in healthcare. Its Healthcare & Life Sciences practice covers biopharmaceuticals, biotechnology, diagnostics, digital health, medtech and more. Recent notable transactions include advising PharmaForceIQ on its investment from Eir Partners and acting as Nominated Adviser/Broker to Diaceutics plc—both active in life sciences marketing/data solutions. The firm's clients include public/private healthcare companies across all subsectors. Key people leading its US Healthcare Investment Banking division include Tom O'Connor (Co-head), Eugene Rozelman (Co-head), Matt Steere (Co-head for MedTech/Diagnostics).